BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Groell F, Jordan O, Borchard G. In vitro models for immunogenicity prediction of therapeutic proteins. European Journal of Pharmaceutics and Biopharmaceutics 2018;130:128-42. [DOI: 10.1016/j.ejpb.2018.06.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ling WL, Lua WH, Gan SK. Sagacity in antibody humanization for therapeutics, diagnostics and research purposes: considerations of antibody elements and their roles. Antib Ther 2020;3:71-9. [PMID: 33928226 DOI: 10.1093/abt/tbaa005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
2 Kibria MG, Akazawa-Ogawa Y, Rahman N, Hagihara Y, Kuroda Y. The immunogenicity of an anti-EGFR single domain antibody (VHH) is enhanced by misfolded amorphous aggregation but not by heat-induced aggregation. Eur J Pharm Biopharm 2020;152:164-74. [PMID: 32416134 DOI: 10.1016/j.ejpb.2020.05.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
3 Melnyk T, Đorđević S, Conejos-Sánchez I, Vicent MJ. Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation. Adv Drug Deliv Rev 2020;160:136-69. [PMID: 33091502 DOI: 10.1016/j.addr.2020.10.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
4 Fasolin L, Pereira R, Pinheiro A, Martins J, Andrade C, Ramos O, Vicente A. Emergent food proteins – Towards sustainability, health and innovation. Food Research International 2019;125:108586. [DOI: 10.1016/j.foodres.2019.108586] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
5 Viola M, Sequeira J, Seiça R, Veiga F, Serra J, Santos AC, Ribeiro AJ. Subcutaneous delivery of monoclonal antibodies: How do we get there? Journal of Controlled Release 2018;286:301-14. [DOI: 10.1016/j.jconrel.2018.08.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 15.3] [Reference Citation Analysis]
6 Mathon C, Bovard D, Dutertre Q, Sendyk S, Bentley M, Hoeng J, Knorr A. Impact of sample preparation upon intracellular metabolite measurements in 3D cell culture systems. Metabolomics 2019;15:92. [PMID: 31190156 DOI: 10.1007/s11306-019-1551-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Vandivort TC, Horton DB, Johnson SB. Regulatory and strategic considerations for addressing immunogenicity and related responses in biopharmaceutical development programs. J Clin Transl Sci 2020;4:547-55. [PMID: 33948231 DOI: 10.1017/cts.2020.493] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Giorgetti SI, Etcheverrigaray M, Terry F, Martin W, De Groot AS, Ceaglio N, Oggero M, Mufarrege EF. Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases. Clin Immunol 2021;233:108888. [PMID: 34798238 DOI: 10.1016/j.clim.2021.108888] [Reference Citation Analysis]
9 Nie S, Wang Z, Moscoso-Castro M, D'Souza P, Lei C, Xu J, Gu J. Biology drives the discovery of bispecific antibodies as innovative therapeutics. Antib Ther 2020;3:18-62. [PMID: 33928225 DOI: 10.1093/abt/tbaa003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
10 Hasan MM, Khatun MS, Kurata H. iLBE for Computational Identification of Linear B-cell Epitopes by Integrating Sequence and Evolutionary Features. Genomics Proteomics Bioinformatics 2020;18:593-600. [PMID: 33099033 DOI: 10.1016/j.gpb.2019.04.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
11 Candini O, Grisendi G, Foppiani EM, Brogli M, Aramini B, Masciale V, Spano C, Petrachi T, Veronesi E, Conte P, Mari G, Dominici M. A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology. Sci Rep 2019;9:7154. [PMID: 31073193 DOI: 10.1038/s41598-019-43613-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
12 Rossotti MA, Bélanger K, Henry KA, Tanha J. Immunogenicity and humanization of single‐domain antibodies. FEBS J. [DOI: 10.1111/febs.15809] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ahsan H. Monoplex and multiplex immunoassays: approval, advancements, and alternatives. Comp Clin Path 2022;31:333-45. [PMID: 34840549 DOI: 10.1007/s00580-021-03302-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mayrhofer P, Kunert R. Nomenclature of humanized mAbs: Early concepts, current challenges and future perspectives. Hum Antibodies 2019;27:37-51. [PMID: 30103312 DOI: 10.3233/HAB-180347] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
15 Hidalgo-cantabrana C, Lucena-prieto MR, Moro-garcía MA, Alonso-arias R, Sánchez B. Whole fractions from probiotic bacteria induce in vitro Th17 responses in human peripheral blood mononuclear cells. Journal of Functional Foods 2018;48:367-73. [DOI: 10.1016/j.jff.2018.07.038] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Tokuda JM, Xie J, Jawa V, Hawkins JM, Ferbas J, Joh NH, Joubert MK. Use of in vitro human skin models to assess potential immune activation in response to biotherapeutic attributes and process-related impurities. Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.xphs.2022.02.001] [Reference Citation Analysis]
17 Bendicho-Lavilla C, Seoane-Viaño I, Otero-Espinar FJ, Luzardo-Álvarez A. Fighting type 2 diabetes: Formulation strategies for peptide-based therapeutics. Acta Pharm Sin B 2022;12:621-36. [PMID: 35256935 DOI: 10.1016/j.apsb.2021.08.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Van Norman GA. Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach? JACC Basic Transl Sci 2019;4:845-54. [PMID: 31998852 DOI: 10.1016/j.jacbts.2019.10.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
19 Cohen S, Chung S. In vitro immunogenicity prediction: bridging between innate and adaptive immunity. Bioanalysis 2021;13:1071-81. [PMID: 34124935 DOI: 10.4155/bio-2021-0077] [Reference Citation Analysis]
20 Kortesoja M, Karhu E, Olafsdottir ES, Freysdottir J, Hanski L. Impact of dibenzocyclooctadiene lignans from Schisandra chinensis on the redox status and activation of human innate immune system cells. Free Radical Biology and Medicine 2019;131:309-17. [DOI: 10.1016/j.freeradbiomed.2018.12.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
21 Golam Kibria M, Akazawa-Ogawa Y, Hagihara Y, Kuroda Y. Immune response with long-term memory triggered by amorphous aggregates of misfolded anti-EGFR VHH-7D12 is directed against the native VHH-7D12 as well as the framework of the analogous VHH-9G8. Eur J Pharm Biopharm 2021;165:13-21. [PMID: 33971271 DOI: 10.1016/j.ejpb.2021.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Duke BR, Mitra-kaushik S. Current In Vitro Assays for Prediction of T Cell Mediated Immunogenicity of Biotherapeutics and Manufacturing Impurities. J Pharm Innov 2020;15:202-18. [DOI: 10.1007/s12247-019-09412-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Cohen S, Myneni S, Batt A, Guerrero J, Brumm J, Chung S. Immunogenicity risk assessment for biotherapeutics through in vitro detection of CD134 and CD137 on T helper cells. MAbs 2021;13:1898831. [PMID: 33729092 DOI: 10.1080/19420862.2021.1898831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]